ERBB2 and breast carcinoma: In our study, mRNA expression of JARID1A was lower in breast cancer tissues, and its down-regulated mRNA expression was obviously related to worse OS in all breast cancer patients, notably in luminal A type, HER2-riched and basal-like type breast cancer patients, which acted the function of tumor suppression.